Northwestern Medicine scientists created a more objective, precise and quicker way to test the effectiveness of multiple sclerosis drugs that may promote the repair of myelin, a protective sheath on neurons.
Northwestern Medicine scientists found that lesions seen in MRIs of knees without any x-ray signs of osteoarthritis predict the development of persistent symptoms of the disease and the first appearance of cartilage damage.
Northwestern Medicine scientists have developed the first animal model for ALS dementia, a form of ALS that also damages the brain, allowing for direct monitoring of test drugs to determine if they work.
Northwestern Medicine scientists developed the first blood test to diagnose major depression in adults and to predict who will benefit from cognitive behavioral therapy.
Mary J.C. Hendrix, PhD, revealed a variance in signaling pathways in embryonic stem cells and metastatic melanoma cells that may impact new therapeutic strategies in cancer.